Human papillomavirus-like particles mediate functional delivery of plasmid DNA to antigen presenting cells in vivo (Q45865913)

17 December 2017

title

Human papillomavirus-like particles mediate functional delivery of plasmid DNA to antigen presenting cells in vivo (English)

1 reference

17 December 2017

author

Stephen Dewhurst

5

1 reference

17 December 2017

author name string

Christine M Malboeuf

1

1 reference

17 December 2017

David A L Simon

2

1 reference

17 December 2017

Young-Eun Ellen Lee

3

1 reference

17 December 2017

Heather A Lankes

4

1 reference

17 December 2017

John G Frelinger

6

1 reference

17 December 2017

Robert C Rose

7

1 reference

17 December 2017

language of work or name

English

0 references

publication date

22 January 2007

1 reference

17 December 2017

number of pages

7

1 reference

based on heuristic

inferred from page(s)

published in

Vaccine

1 reference

17 December 2017

volume

25

1 reference

17 December 2017

issue

17

1 reference

17 December 2017

page(s)

3270-3276

1 reference

17 December 2017

ACOG Practice Bulletin. Clinical Management Guidelines for Obstetrician-Gynecologists. Number 61, April 2005. Human papillomavirus

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.01.067

Role for centromeric heterochromatin and PML nuclear bodies in the cellular response to foreign DNA.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.01.067

Detection of neutralizing antibodies against human papillomaviruses (HPV) by inhibition of gene transfer mediated by HPV pseudovirions.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.01.067

Gene transfer using human papillomavirus pseudovirions varies according to virus genotype and requires cell surface heparan sulfate.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.01.067

Establishment of papillomavirus infection is enhanced by promyelocytic leukemia protein (PML) expression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.01.067

Classification of papillomaviruses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.01.067

Heterologous papillomavirus virus-like particles and human papillomavirus virus-like particle immune complexes activate human Langerhans cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.01.067

Chimeric papillomavirus virus-like particles elicit antitumor immunity against the E7 oncoprotein in an HPV16 tumor model

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.01.067

A membrane-destabilizing peptide in capsid protein L2 is required for egress of papillomavirus genomes from endosomes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.01.067

Cell cycle-dependent association of PML bodies with sites of active transcription in nuclei of mammalian cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.01.067

Papillomavirus L1 major capsid protein self-assembles into virus-like particles that are highly immunogenic

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.01.067

Sustained ex vivo and in vivo transfer of a reporter gene using polyoma virus pseudocapsids

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.01.067

Virus-like gene transfer into cells mediated by polyoma virus pseudocapsids

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.01.067

Migration and maturation of Langerhans cells in skin transplants and explants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.01.067

Papillomavirus-like particles induce acute activation of dendritic cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.01.067

Coming soon: cervical cancer vaccines, and an array of public health issues

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.01.067

Chimeric papillomavirus-like particles

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.01.067

Against which human papillomavirus types shall we vaccinate and screen? The international perspective

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.01.067

Persistence of human papillomavirus type 16 infection is associated with lack of cytotoxic T lymphocyte response to the E6 antigens

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.01.067

Global cancer statistics, 2002

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.01.067

Development of a DNA vaccine targeting human papillomavirus type 16 oncoprotein E6.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.01.067

Serological differentiation of human papillomavirus types 11, 16 and 18 using recombinant virus-like particles

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.01.067

Expression of the full-length products of the human papillomavirus type 6b (HPV-6b) and HPV-11 L2 open reading frames by recombinant baculovirus, and antigenic comparisons with HPV-11 whole virus particles

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.01.067

Immune response to human papillomavirus 16 L1E7 chimeric virus-like particles: induction of cytotoxic T cells and specific tumor protection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.01.067

In vitro gene transfer using human papillomavirus-like particles

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.01.067

Papillomaviruses and cancer: from basic studies to clinical application

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.01.067

10.1016/J.VACCINE.2007.01.067

7 January 2021

Identifiers

DOI

1 reference

17 December 2017

release_rtn3mvwpgnfflk2yjnrf3xepcq

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/rtn3mvwpgnfflk2yjnrf3xepcq

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference

17 December 2017